Targeted radiotherapy of pigmented melanoma with 131I-5-IPN
Abstract Purpose There has been no satisfactory treatment for advanced melanoma until now. Targeted radionuclide therapy (TRNT) may be a promising option for this heretofore lethal disease. Our goal in this study was to synthesize 131I-N-(2-(diethylamino)ethyl)-5-(iodo-131I)picolinamide (131I-5-IPN)...
Main Authors: | Xiaodong Xu, Lujie Yuan, Yongkang Gai, Qingyao Liu, Lianglan Yin, Yaqun Jiang, Yichun Wang, Yongxue Zhang, Xiaoli Lan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-018-0983-0 |
Similar Items
-
Correction to: Targeted radiotherapy of pigmented melanoma with 131I-5-IPN
by: Xiaodong Xu, et al.
Published: (2019-03-01) -
Targeting Melanin in Melanoma with Radionuclide Therapy
by: Kevin J. H. Allen, et al.
Published: (2022-08-01) -
Development of Radiofluorinated Nicotinamide/Picolinamide Derivatives as Diagnostic Probes for the Detection of Melanoma
by: Yi-Hsuan Lo, et al.
Published: (2021-06-01) -
Melanogenesis and the Targeted Therapy of Melanoma
by: Cang Li, et al.
Published: (2022-12-01) -
(E)-N,N′-(1,2-Dicyanoethene-1,2-diyl)dipicolinamide
by: Maciej Posel, et al.
Published: (2016-09-01)